The zebrafish is emerging as a powerful system for human cancer modeling. Its greatest asset resides in the combination of genetic versatility and the possibility to perform high throughput screenings of chemical libraries enabling fast identification of anti-tumoral drugs in a whole organism cancer model.

Such large-scale assays require the generation of fish in which protein of interest is inactivated using the CRISPR technology.

For more information on the zebrafish platform, please click here.

Contact [info@b2h.be] us to discuss how these capabilities can forward your projects! We will help you develop tailored solutions.